WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Earnings & Revenue

ARQT past revenue growth

How has ARQT's revenue growth performed historically?
Company
1,545.18%
Industry
83.05%
Market
15.22%
ARQT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARQT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARQT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARQT earnings and revenue history

Current Revenue
$106.4M
Current Earnings
-$217.4M
Current Profit Margin
-204.4%

ARQT Return on Equity

Current Company
-197.3%
Current Industry
16.7%
Current Market
28.2%
ARQT's Return on Equity (-197.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ARQT announces earnings.

ARQT Return on Assets

Current Company
-60.7%
Current Industry
3.2%
ARQT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARQT Return on Capital Employed

Current Company
-42.65%
Current Industry
-43.6%
ARQT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARQT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARQT$106.39M-$182.01M-$217.42M+1,545.18%N/A
AUTL$10.50M-$146.22M-$221.26M+28.38%N/A
ABCL$35.79M-$138.09M-$146.90M-97.15%N/A
SAVA$0.00-$46.45M-$47.90MN/AN/A
PHVS$0.00-$111.71M-$114.26MN/AN/A

ARQT earnings dates

Next earnings date
Jun 14, 2024

Arcutis Biotherapeutics Earnings & Revenue FAQ

What were ARQT's earnings last quarter?

On Invalid Date, Arcutis Biotherapeutics (NASDAQ: ARQT) reported Q1 2024 earnings per share (EPS) of -$0.32, up 75.57% year over year. Total Arcutis Biotherapeutics earnings for the quarter were -$35.38 million. In the same quarter last year, Arcutis Biotherapeutics's earnings per share (EPS) was -$1.31.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.

What was ARQT's earnings growth in the past year?

As of Q2 2024, Arcutis Biotherapeutics's earnings has grown year over year. Arcutis Biotherapeutics's earnings in the past year totalled -$217.42 million.

What is ARQT's earnings date?

Arcutis Biotherapeutics's earnings date is Invalid Date. Add ARQT to your watchlist to be reminded of ARQT's next earnings announcement.

What was ARQT's revenue last quarter?

On Invalid Date, Arcutis Biotherapeutics (NASDAQ: ARQT) reported Q1 2024 revenue of $49.57 million up 1,682.42% year over year. In the same quarter last year, Arcutis Biotherapeutics's revenue was $2.78 million.

What was ARQT's revenue growth in the past year?

As of Q2 2024, Arcutis Biotherapeutics's revenue has grown 1,545.18% year over year. This is 1,462.13 percentage points higher than the US Biotechnology industry revenue growth rate of 83.05%. Arcutis Biotherapeutics's revenue in the past year totalled $106.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.